SCHEMBL185393

SCHEMBL185393

NC1CC1.O=C(O)NCc1ccc(Nc2ccc(Cl)cc2C(F)(F)F)cn1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 12/20 0.42
RAB9A P51151 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
KIT P10721 2/20 0.39
FLT3 P36888 2/20 0.39
CNR1 P21554 2/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL14856625 0.97 CNR2 (0.40) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185476 0.90 KIT (0.40) CNR2KITFLT3CNR1
SCHEMBL185808 0.89 FLT3 (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185747 0.88 CNR2 (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185884 0.87 CNR2 (0.38) CNR2RAB9ACYP1A2CYP2D6CYP2C19
Trifluoroacetic Acid SCHEMBL14856648 0.86 FLT3 (0.38) CNR2RAB9AKITFLT3
SCHEMBL184937 0.85 F11 (0.41) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL186629 0.84 HTR2A (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL2811071 0.84 RAB9A (0.44) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL2805697 0.83 RAB9A (0.41) CNR2RAB9ACYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539323-B3 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2017-10-04 EP disclosed
EP-2539323-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2014-12-03 EP disclosed
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2539323-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2013-01-02 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2011104203-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-01 WO disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed